AIHealthcare

Schrödinger is a publicly traded scientific software and biotechnology company that develops a physics-based computational platform, augmented by AI and machine learning, for drug discovery and materials science. The company’s mission is to improve human health and quality of life by transforming how therapeutics and materials are discovered, and it operates a dual business model spanning software licensing and internal/external drug discovery collaborations.